Analytic Investors’s West Pharmaceutical WST Stock Holding History

Analytic Investors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.87M	Sell	25,137 -10,955	-30%	-$870K	0.02%	285
2016 Q2	$2.74M	Buy	36,092 +1,882	+6%	+$137K	0.03%	241
2016 Q1	$2.37M	Sell	34,210 -3,106	-8%	-$187K	0.03%	287
2015 Q4	$2.25M	Sell	37,316 -21,177	-36%	-$1.27M	0.03%	277
2015 Q3	$3.17M	Buy	+58,493	New	+$3.41M	0.04%	238
2014 Q2	–	Sell	-5,216	Closed	-$230K	–	609
2014 Q1	$230K	Sell	5,216 -8,941	-63%	-$421K	﹤0.01%	528
2013 Q4	$695K	Sell	14,157 -515	-4%	-$24.1K	0.01%	345
2013 Q3	$604K	Buy	14,672 +2,914	+25%	+$111K	0.01%	352
2013 Q2	$413K	Buy	+11,758	New	+$387K	0.01%	465

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Analytic Investors's WST Position: Q3 2016 in Review

Analytic Investors reduced its West Pharmaceutical (WST) stake by 30% in Q3 2016, selling an estimated $870K and leaving 25,137 shares worth $1.87M. The position accounts for 0.02% of the portfolio, ranked #285.

Analytic Investors first reported a position in WST in Q2 2013 and has held it in 9 quarters since. The position peaked at $3.17M in Q3 2015. 278 funds tracked by Wall St. Rank hold WST as of Q3 2016.

Analytic Investors held 25,137 shares of West Pharmaceutical worth $1.87M as of Q3 2016.
Analytic Investors sold 10,955 West Pharmaceutical shares in Q3 2016, an estimated $870K.
West Pharmaceutical made up 0.02% of Analytic Investors's portfolio in Q3 2016, its #285 holding.
Analytic Investors first reported a position in West Pharmaceutical in Q2 2013 and has held it in 9 quarters since.
Analytic Investors's West Pharmaceutical position peaked at $3.17M in Q3 2015.
278 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.